CSL Behring Scales Global HCP Engagement and Attracts new HCPs with the ON24 Platform
CSL Behring, a global leader in biotherapeutics, has significantly scaled its healthcare professional (HCP) engagement program using the ON24 platform. Leveraging ON24's intelligent engagement solutions, CSL Behring has enhanced its digital engagement, resulting in new potential customers and better insights into customer content engagement. The integration with Veeva CRM allows real-time data capture and analysis, informing follow-up strategies and deepening customer relationships. Before partnering with ON24, CSL Behring faced challenges with disjointed digital tools and manual processes that hindered scalability. Now, the company offers consistent, meaningful content to HCPs globally through live and on-demand webinars, reaching thousands of HCPs and increasing engagement. This transformation has enabled CSL Behring to expand its reach without adding headcount, repurposing content across 40 countries. The life sciences industry saw a 13% year-over-year increase in digital experiences in 2023, emphasizing the sector's shift towards omnichannel strategies.
CSL Behring, un leader globale nei bioterapeutici, ha notevolmente ampliato il suo programma di coinvolgimento dei professionisti sanitari (HCP) utilizzando la piattaforma ON24. Sfruttando le soluzioni di coinvolgimento intelligente di ON24, CSL Behring ha migliorato il suo coinvolgimento digitale, risultando in nuovi potenziali clienti e migliori approfondimenti sull'interazione con i contenuti dei clienti. L'integrazione con Veeva CRM consente la cattura e l'analisi dei dati in tempo reale, informando le strategie di follow-up e approfondendo le relazioni con i clienti. Prima di collaborare con ON24, CSL Behring affrontava sfide con strumenti digitali disgiunti e processi manuali che ostacolavano la scalabilità. Ora, l'azienda offre contenuti coerenti e significativi agli HCP a livello globale attraverso webinar dal vivo e on-demand, raggiungendo migliaia di HCP e aumentando il coinvolgimento. Questa trasformazione ha permesso a CSL Behring di espandere la propria portata senza aumentare il personale, riutilizzando contenuti in 40 paesi. L'industria delle scienze della vita ha visto un aumento del 13% delle esperienze digitali anno dopo anno nel 2023, sottolineando il cambiamento del settore verso strategie omnicanale.
CSL Behring, un líder mundial en bioterapéuticos, ha ampliado significativamente su programa de compromiso con los profesionales de la salud (HCP) utilizando la plataforma ON24. Aprovechando las soluciones de compromiso inteligente de ON24, CSL Behring ha mejorado su participación digital, lo que ha resultado en nuevos clientes potenciales y mejores conocimientos sobre la interacción del cliente con los contenidos. La integración con Veeva CRM permite la captura y análisis de datos en tiempo real, informando las estrategias de seguimiento y profundizando las relaciones con los clientes. Antes de asociarse con ON24, CSL Behring enfrentaba desafíos con herramientas digitales desarticuladas y procesos manuales que dificultaban la escalabilidad. Ahora, la compañía ofrece contenidos consistentes y significativos a los HCPs a nivel global a través de seminarios web en vivo y bajo demanda, alcanzando a miles de HCPs y aumentando el compromiso. Esta transformación ha permitido a CSL Behring expandir su alcance sin aumentar la plantilla, reutilizando contenidos en 40 países. La industria de las ciencias de la vida vio un aumento del 13% en experiencias digitales interanuales en 2023, enfatizando el cambio del sector hacia estrategias omnicanal.
CSL Behring는 생물의약품 분야의 글로벌 리더로서 ON24 플랫폼을 활용하여 의료 전문가(HCP) 참여 프로그램을 대폭 확장했습니다. ON24의 스마트 참여 솔루션을 활용하여 CSL Behring는 디지털 참여를 향상시켰고, 그 결과 새로운 잠재 고객과 고객 콘텐츠 참여에 대한 더 나은 통찰력을 얻었습니다. Veeva CRM과의 통합은 실시간 데이터 수집 및 분석을 가능하게 하여 후속 전략을 알리고 고객 관계를 심화합니다. ON24와의 파트너십 이전에 CSL Behring는 조화되지 않은 디지털 도구와 수동 프로세스의 문제로 인해 확장성에 어려움을 겪었습니다. 이제 이 회사는 생중계 및 주문형 웨비나를 통해 전 세계 HCP에게 일관되고 의미 있는 콘텐츠를 제공하여 수천 명의 HCP에 도달하고 참여도를 높이고 있습니다. 이러한 혁신 덕분에 CSL Behring는 직원 수를 늘리지 않고도 범위를 확장할 수 있었으며, 40개국에서 콘텐츠를 재활용하고 있습니다. 생명과학 산업은 2023년에 디지털 경험이 전년 대비 13% 증가했으며, 이는 이 분야가 옴니채널 전략으로 전환하고 있음을 강조합니다.
CSL Behring, un leader mondial dans le domaine des biothérapeutiques, a considérablement élargi son programme d'engagement auprès des professionnels de la santé (HCP) en utilisant la plateforme ON24. En s'appuyant sur les solutions d'engagement intelligent d'ON24, CSL Behring a amélioré son engagement numérique, ce qui a entraîné de nouveaux clients potentiels et de meilleures connaissances sur l'engagement des clients avec le contenu. L'intégration avec Veeva CRM permet une capture et une analyse des données en temps réel, informant les stratégies de suivi et approfondissant les relations avec les clients. Avant de s'associer à ON24, CSL Behring faisait face à des défis liés à des outils numériques déconnectés et à des processus manuels qui freinaient sa scalabilité. Aujourd'hui, l'entreprise propose un contenu cohérent et significatif aux HCP à l'échelle mondiale à travers des webinaires en direct et à la demande, atteignant des milliers de HCP et augmentant l'engagement. Cette transformation a permis à CSL Behring d'élargir sa portée sans ajouter de personnel, en réutilisant des contenus dans 40 pays. Le secteur des sciences de la vie a connu une augmentation de 13 % des expériences numériques d'une année sur l'autre en 2023, soulignant le passage du secteur vers des stratégies omnicanal.
CSL Behring, ein globaler Marktführer im Bereich der Biotherapeutika, hat sein Programm zur Einbindung von Gesundheitsfachkräften (HCP) mithilfe der ON24-Plattform erheblich erweitert. Durch den Einsatz der intelligenten Engagement-Lösungen von ON24 hat CSL Behring sein digitales Engagement verbessert, was zu neuen potenziellen Kunden und besseren Einblicken in das Kundenengagement mit Inhalten führt. Die Integration mit Veeva CRM ermöglicht eine Echtzeit-Datenerfassung und -analyse, die die Strategien für Nachverfolgung informiert und die Kundenbeziehungen vertieft. Vor der Zusammenarbeit mit ON24 sah sich CSL Behring mit Herausforderungen durch disparate digitale Tools und manuelle Prozesse konfrontiert, die die Skalierbarkeit behinderten. Jetzt bietet das Unternehmen weltweit konsistente und relevante Inhalte für HCPs durch Live- und On-Demand-Webinars an, wodurch Tausende von HCPs erreicht und das Engagement gesteigert werden. Diese Transformation hat es CSL Behring ermöglicht, seine Reichweite zu erweitern, ohne zusätzliche Mitarbeiter einzustellen und Inhalte in 40 Ländern wiederzuverwenden. Die Lebenswissenschaftsbranche verzeichnete im Jahr 2023 einen Anstieg der digitalen Erlebnisse um 13% im Vergleich zum Vorjahr, was den Wandel der Branche hin zu Omnichannel-Strategien unterstreicht.
- CSL Behring scaled its HCP engagement program, reaching thousands of HCPs.
- Increased customer engagement through live and on-demand webinars.
- Enhanced data-driven insights, informing follow-up strategies.
- Expanded reach without adding headcount, repurposing content across 40 countries.
- Integration with Veeva CRM for real-time data capture and analysis.
- Prior challenges with disjointed digital engagement tools and manual processes.
Insights
Leveraging ON24, CSL Behring scaled their global healthcare professional (HCP) education, improving data-driven insights through digital engagement
CSL Behring is a global leader in the field of biotherapeutics, driven by its promise to save lives. The team needed to deliver a consistent experience for HCPs — at scale — while capturing actionable customer insights that were integrated with Veeva CRM to make informed decisions across the organization. CSL Behring knew that customers wanted to attend virtual and/or live events, but not all affiliates had a suitable platform to conduct them.
“ON24 has helped us reach a thousand HCPs and attracted hundreds of new potential customers to our programs. It truly helps our business,” said Stuart Davis, Director, Commercial Enablement, Marketing, CSL Behring. “The ability to create on-demand webinars has allowed us to increase customer engagement, implementing an always-on engagement strategy has helped increase our reach and engage HCPs across the globe.”
Before partnering with ON24, CSL Behring faced challenges with disjointed digital engagement tools, which didn’t integrate with their CRM or offer comprehensive first-party engagement data. Manual processes slowed scalability and the team was unable to provide consistent, meaningful content to its HCP audience. By leveraging the ON24 Intelligent Engagement Platform solutions — from interactive content hubs to on-demand webinars — CSL Behring can deliver content at scale but also capture and analyze audience behavior in real-time.
Now, CSL Behring runs an integrated education program for its HCPs, with both live and on-demand options. By streamlining event creation and enabling affiliates to repurpose content across 40 countries, CSL Behring has increased the reach of its program without adding headcount. The ON24 integration with Veeva CRM ensures that the HCP first-party engagement data flows directly to CSL Behring customer facing teams, informing follow-up strategies and deepening customer relationships.
"Life sciences companies operate in a highly regulated environment, where maintaining compliance while adapting to evolving patient and provider needs is crucial," said Callan Young, CMO of ON24. "We’re proud to support CSL Behring in their mission to deliver life-saving therapies by helping them enhance healthcare professional education and drive sustainable growth through personalized, data-driven digital experiences."
Learn more about how CSL Behring transformed its HCP engagement program powered by ON24 by reading the full case study here.
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL (ASX:CSL; USOTC:CSLLY), headquartered in
About ON24
ON24 is on a mission to help businesses bring their go-to-market strategy into the AI era and drive cost-effective revenue growth. Through its leading intelligent engagement platform, ON24 enables customers to combine best-in-class experiences with personalization and content, to capture and act on connected insights at scale.
ON24 provides industry-leading companies, including 4 of the 5 largest global software companies, 3 of the 5 top global asset management firms, 3 of the 5 largest global healthcare companies and 3 of the 5 largest global industrial companies, with a valuable source of first-party data to drive sales and marketing innovation, improve efficiency and increase business results. Headquartered in
Forward-Looking Statements
This document contains “forward-looking statements” under applicable securities laws. In some cases, such statements can be identified by words such as: “expect,” “convert,” “believe,” “plan,” “future,” “may,” “should,” “will,” and similar references to future periods. Forward-looking statements include express or implied statements regarding our ability to achieve our business strategies, growth, or other future events or conditions. Such statements are based on our current beliefs, expectations, and assumptions about future events or conditions, which are subject to inherent risks and uncertainties, including the risks and uncertainties discussed in the filings we make from time to time with the Securities and Exchange Commission. Actual results may differ materially from those indicated in forward-looking statements, and you should not place undue reliance on them. All statements herein are based only on information currently available to us and speak only as of the date hereof. Except as required by law, we undertake no obligation to update any such statement.
© 2024 ON24, Inc. All rights reserved. ON24 and the ON24 logo are trademarks owned by ON24, Inc., and are registered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209540705/en/
Media:
Gabriella Bello Kose
press@on24.com
Investor:
Irmina Blaszczyk, The Blueshirt Group for ON24
investorrelations@on24.com
Source: ON24
FAQ
How did CSL Behring scale its HCP engagement program using ON24?
What impact did the ON24 platform have on CSL Behring's customer engagement?
What challenges did CSL Behring face before partnering with ON24?
How does the ON24 platform integrate with Veeva CRM for CSL Behring?
What was the year-over-year increase in digital experiences in the life sciences industry in 2023?
